Skip to main navigation Skip to search Skip to main content

Endeavor BioMedicines to Present New Data From Phase 2a Clinical Trial of ENV-101 at American Thoracic Society 2024 International Conference

  • Michael Maher

Press/Media

Period1 May 2024

Media coverage

8

Media coverage